Exact Mass: 531.2016832
Exact Mass Matches: 531.2016832
Found 61 metabolites which its exact mass value is equals to given mass value 531.2016832
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Phaseolotoxin
Rupatadine Fumarate
C30H30ClN3O4 (531.1924730000001)
Rupatadine (UR-12592) Fumarate is a potent, orally active and long-lasting dual PAF/H1 antagonist, with Kis of 0.55 μM and 0.1 μM, respectively. Rupatadine Fumarate can be used for the research of allergic rhinitis and urticaria[1][2][3].
3-[[2-(2-Benzoyl-N-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]anilino)-2-oxoethyl]carbamoylamino]benzoic acid
Asn His Phe Asp
Asn Phe His Asp
Asp Asp Pro Trp
C24H29N5O9 (531.1965184000001)
Asp Asp Trp Pro
C24H29N5O9 (531.1965184000001)
Asp Phe His Asn
Asp Phe Asn His
Asp His Phe Asn
Asp His Asn Phe
Asp Asn Phe His
Asp Asn His Phe
Asp Pro Asp Trp
C24H29N5O9 (531.1965184000001)
Asp Pro Trp Asp
C24H29N5O9 (531.1965184000001)
Asp Trp Asp Pro
C24H29N5O9 (531.1965184000001)
Asp Trp Pro Asp
C24H29N5O9 (531.1965184000001)
Phe Asp His Asn
Phe Asp Asn His
Phe His Asp Asn
Phe His Asn Asp
Phe Asn Asp His
Phe Asn His Asp
His Asp Phe Asn
His Asp Asn Phe
His Phe Asp Asn
His Phe Asn Asp
His Met Met Asn
His Met Asn Met
His Asn Asp Phe
His Asn Phe Asp
His Asn Met Met
Met His Met Asn
Met His Asn Met
Met Met His Asn
Met Met Asn His
Met Asn His Met
Met Asn Met His
Asn Asp Phe His
Asn Asp His Phe
Asn Phe Asp His
Asn His Asp Phe
Asn His Met Met
Asn Met His Met
Asn Met Met His
Pro Asp Asp Trp
C24H29N5O9 (531.1965184000001)
Pro Asp Trp Asp
C24H29N5O9 (531.1965184000001)
Pro Trp Asp Asp
C24H29N5O9 (531.1965184000001)
Trp Asp Asp Pro
C24H29N5O9 (531.1965184000001)
Trp Asp Pro Asp
C24H29N5O9 (531.1965184000001)
Trp Pro Asp Asp
C24H29N5O9 (531.1965184000001)
butropium bromide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
(3-fluorophenyl)-[(1R)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone
(3-fluorophenyl)-[(1S)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-2,4-diphenylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
DO34
DO34 is a highly potent, selective and centrally active diacylglycerol lipase (DAGL) inhibitor, with an IC50 of 6 nM for DAGLα conversion of SAG to 2-AG, and an IC50 for DAGLβ.
DO34 analog
DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100.